Last updated: March 14, 2021
Sponsor: Clinical Research Centre, Malaysia
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vomiting
Stomach Discomfort
Lactose Intolerance
Treatment
N/AClinical Study ID
NCT04801277
NMRR-19-3279-51524
Ages 18-45 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Parturients (36-42 weeks pregnant) aged 18-45 undergoing planned for CaesareanSection.
- American Society of Anaesthesiology class II patients only
Exclusion
Exclusion Criteria:
- Patients with a previous history of PONV or nausea and vomiting in the preceding 24hours
- Patients who required emergent surgery where delay is inappropriate and can compromisemother and foetus, e.g. foetal distress, foetal bradycardia, chorioamnionitis, cordprolapse, severe preeclampsia
- Patients with documented or known history of allergy to granisetron
- Morbid obesity (BMI>40) as morbid obesity patient will be not be given intrathecalmorphine due to increase risk of post operative respiratory depression.
- Patients using any antiemetic drug including dexamethasone for 24 hours prior toCaesarean section (CS)
- Patient who had an implanted pacemaker or defibrillator device. (safety of the use ofelectroacupuncture on these patient is questionable)
- Patient who received opioids prior to CS (opioid is known to have nausea and vomitingside effect)
- Patient refusal
- Severe preeclampsia, gestational diabetes mellitus on treatment, neurological orcardiac disease.
Study Design
Total Participants: 100
Study Start date:
September 01, 2020
Estimated Completion Date:
April 30, 2021
Study Description
Connect with a study center
Hospital Raja Permaisuri Bainun Ipoh
Ipoh, Perak 30450
MalaysiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.